Gesamtlänge aller Episoden: 2 days 6 hours 13 minutes
Defining the Role of SGLT2 Inhibitors for Your Patient With Type 2 Diabetes
Secretory Pituitary Adenomas: What Are the New Treatment Options on the Horizon?
Go online to www.peervoice.com/h/pvr116 to view the entire programme with slides.
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach
State of the Science in CKD: New Treatment, New Outcomes